VYMADA 50 MG 14 TABLETS | Sacubitril + Valsartan for Heart Failure
VYMADA 50 MG 14 TABLETS contain Sacubitril 24 mg and Valsartan 26 mg, a prescription ARNI medicine used to treat chronic heart failure and reduce the risk of hospitalization and cardiovascular death.
VYMADA 50 MG 14 TABLETS
VYMADA 50 MG 14 TABLETS (Sacubitril 24 mg + Valsartan 26 mg): Comprehensive Guide and Benefits
Introduction to VYMADA 50 MG 14 TABLETS
ARNI Therapy for Chronic Heart Failure
VYMADA 50 MG 14 TABLETS are a prescription-only medicine containing Sacubitril 24 mg and Valsartan 26 mg. This combination belongs to the class of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) and is indicated for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). It helps improve heart function, reduce the risk of hospitalization due to heart failure, and lower the risk of cardiovascular death when used as part of a comprehensive treatment plan.
Key Benefits of VYMADA 50 MG 14 TABLETS
Helps improve the heart's pumping efficiency.
Reduces the risk of hospitalization due to chronic heart failure.
Lowers the risk of cardiovascular death.
Helps relieve symptoms such as breathlessness, fatigue, and swelling.
Supports improved quality of life when used with standard heart failure therapy.
How VYMADA 50 MG Works
VYMADA combines two medicines with complementary actions:
Sacubitril inhibits the enzyme neprilysin, increasing beneficial natriuretic peptides that help relax blood vessels, promote sodium excretion, and reduce strain on the heart.
Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and decreases the workload on the heart.
Together, these actions improve cardiac function and slow the progression of chronic heart failure.
Usage Instructions
Take exactly as prescribed by your healthcare provider.
May be taken with or without food.
Swallow the tablet whole with water.
Take it at the same time every day.
Continue treatment regularly even if you feel well.
Do not stop taking the medicine without consulting your doctor.
Medicinal Advantages
Proven treatment for chronic heart failure with reduced ejection fraction.
Helps reduce heart failure-related hospitalizations.
Lowers cardiovascular mortality.
Combines two complementary mechanisms in one tablet.
Convenient oral therapy for long-term heart failure management.
NOTE: VYMADA should not be used together with an ACE inhibitor. A washout period of at least 36 hours is required when switching from an ACE inhibitor to VYMADA to reduce the risk of angioedema.
Off-Label Uses
VYMADA should generally be used only for its approved indication in chronic heart failure unless otherwise recommended by a cardiologist.
Expert Advice
Monitor your blood pressure regularly.
Attend scheduled kidney function and potassium blood tests.
Follow a low-sodium diet if advised.
Take all prescribed heart failure medications consistently.
Seek immediate medical attention if you develop swelling of the face, lips, tongue, or difficulty breathing.
Precautions
Pregnancy & Breastfeeding
Do not use VYMADA during pregnancy, as it may cause serious harm to the unborn baby. Breastfeeding is generally not recommended unless advised by your healthcare provider.
Kidney & Liver Function
Use cautiously in patients with kidney or liver impairment. Regular monitoring of kidney function and serum potassium is recommended during treatment. Dose adjustments may be required in certain patients.
Drug Interactions
Inform your healthcare provider if you are taking:
ACE inhibitors.
Other ARBs.
Potassium supplements or potassium-sparing diuretics.
NSAIDs (such as ibuprofen or diclofenac).
Lithium.
Aliskiren.
These medicines may increase the risk of serious drug interactions.
Existing Medical Conditions
Tell your healthcare provider if you have:
Chronic heart failure.
Kidney disease.
Liver disease.
Low blood pressure.
History of angioedema.
Diabetes.
Storage Instructions
Store below 30°C.
Keep in the original blister pack.
Protect from moisture and excessive heat.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is VYMADA 50 MG used for?
A: It is used to treat chronic heart failure, helping reduce the risk of hospitalization and cardiovascular death while improving heart function.
Q: What are the active ingredients?
A: Each tablet contains Sacubitril 24 mg and Valsartan 26 mg.
Q: What are the common side effects?
A: Common side effects include low blood pressure, dizziness, cough, increased potassium levels, impaired kidney function, tiredness, and nausea.
Q: Can I take VYMADA with an ACE inhibitor?
A: No. A minimum 36-hour washout period is required between stopping an ACE inhibitor and starting VYMADA.
Q: Can I stop taking VYMADA if I feel better?
A: No. Continue taking the medicine as prescribed. Stopping treatment without medical advice may worsen heart failure.
Q: Is VYMADA available without a prescription?
A: No. VYMADA 50 MG is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Product Tags
VYMADA 50 MG 14 TABLETS, Sacubitril 24 mg, Valsartan 26 mg, Sacubitril Valsartan Tablet, ARNI Medicine, Heart Failure Treatment, Chronic Heart Failure, HFrEF Medicine, Cardiovascular Medicine, Prescription Heart Medicine, Heart Failure Therapy, Blood Pressure Medicine, Cardiac Care, Angiotensin Receptor Neprilysin Inhibitor, Heart Function Support, Novartis VYMADA, Sacubitril Valsartan 50 mg, Heart Failure Medication, Prescription Cardiovascular Tablet, Chronic Heart Failure Management.
